LymphedemaV1, PubMed, Corpus, bibRecord, 003328

Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema.

Identifieur interne : 003328 ( PubMed/Corpus ); précédent : 003327; suivant : 003329

Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema.

Auteurs : J H Hwang ; J Y Choi ; J Y Lee ; S H Hyun ; Y. Choi ; Y S Choe ; K H Lee ; B T Kim

Source :

Lymphology [ 0024-7766 ] ; 2007.

RBID : pubmed:18365531

English descriptors

KwdEn :
- Adult, Antimony, Extremities, Female, Humans, Lymphedema (diagnostic imaging), Lymphedema (therapy), Lymphoscintigraphy, Male, Middle Aged, Physical Therapy Modalities, Sensitivity and Specificity, Technetium Compounds.
MESH :
- chemical : Antimony, Technetium Compounds.
- diagnostic imaging : Lymphedema.
- therapy : Lymphedema.
- Adult, Extremities, Female, Humans, Lymphoscintigraphy, Male, Middle Aged, Physical Therapy Modalities, Sensitivity and Specificity.

Abstract

We investigated whether baseline lymphscintigraphic findings can predict long-term response to complex physical therapy (CPT) in patients with early stage extremity lymphedema. Twenty patients with unilateral extremity lymphedema of clinical stage I or II underwent CPT after baseline lymphscintigraphy. Therapeutic responses (good vs. poor) were evaluated at 1 year post-CPT based on changes in skin status and subjective symptoms, and percent volume reductions and compared with clinical factors and lymphscintigraphic findings. Eleven patients showed good response to CPT with significant volume reduction of edematous extremities, and no significant volume reduction was observed in the remaining 9. Patients with good or poor responses to CPT showed no significant differences in terms of clinical variables. However, significant differences were observed between the lymphscintigraphic findings of these patients. More specifically, a lymphscintigraphic finding of main lymphatic vessels without collateral lymphatic vessels was the best predictor for a good response to CPT; the sensitivity, specificity and accuracy of this lymphscintigraphic finding is 91% (10/11), 100% (9/9) and 95% (19/20), respectively. In patients with unilateral extremity lymphedema of early stage, baseline lymphscintigraphy may usefully predict long-term response to CPT.

PubMed: 18365531

Links to Exploration step

pubmed:18365531

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema.</title>
<author><name sortKey="Hwang, J H" sort="Hwang, J H" uniqKey="Hwang J" first="J H" last="Hwang">J H Hwang</name>
<affiliation><nlm:affiliation>Department of Physical Medicine and Rehabilitation, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Choi, J Y" sort="Choi, J Y" uniqKey="Choi J" first="J Y" last="Choi">J Y Choi</name>
</author>
<author><name sortKey="Lee, J Y" sort="Lee, J Y" uniqKey="Lee J" first="J Y" last="Lee">J Y Lee</name>
</author>
<author><name sortKey="Hyun, S H" sort="Hyun, S H" uniqKey="Hyun S" first="S H" last="Hyun">S H Hyun</name>
</author>
<author><name sortKey="Choi, Y" sort="Choi, Y" uniqKey="Choi Y" first="Y" last="Choi">Y. Choi</name>
</author>
<author><name sortKey="Choe, Y S" sort="Choe, Y S" uniqKey="Choe Y" first="Y S" last="Choe">Y S Choe</name>
</author>
<author><name sortKey="Lee, K H" sort="Lee, K H" uniqKey="Lee K" first="K H" last="Lee">K H Lee</name>
</author>
<author><name sortKey="Kim, B T" sort="Kim, B T" uniqKey="Kim B" first="B T" last="Kim">B T Kim</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:18365531</idno>
<idno type="pmid">18365531</idno>
<idno type="wicri:Area/PubMed/Corpus">003328</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003328</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema.</title>
<author><name sortKey="Hwang, J H" sort="Hwang, J H" uniqKey="Hwang J" first="J H" last="Hwang">J H Hwang</name>
<affiliation><nlm:affiliation>Department of Physical Medicine and Rehabilitation, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Choi, J Y" sort="Choi, J Y" uniqKey="Choi J" first="J Y" last="Choi">J Y Choi</name>
</author>
<author><name sortKey="Lee, J Y" sort="Lee, J Y" uniqKey="Lee J" first="J Y" last="Lee">J Y Lee</name>
</author>
<author><name sortKey="Hyun, S H" sort="Hyun, S H" uniqKey="Hyun S" first="S H" last="Hyun">S H Hyun</name>
</author>
<author><name sortKey="Choi, Y" sort="Choi, Y" uniqKey="Choi Y" first="Y" last="Choi">Y. Choi</name>
</author>
<author><name sortKey="Choe, Y S" sort="Choe, Y S" uniqKey="Choe Y" first="Y S" last="Choe">Y S Choe</name>
</author>
<author><name sortKey="Lee, K H" sort="Lee, K H" uniqKey="Lee K" first="K H" last="Lee">K H Lee</name>
</author>
<author><name sortKey="Kim, B T" sort="Kim, B T" uniqKey="Kim B" first="B T" last="Kim">B T Kim</name>
</author>
</analytic>
<series><title level="j">Lymphology</title>
<idno type="ISSN">0024-7766</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antimony</term>
<term>Extremities</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphedema (diagnostic imaging)</term>
<term>Lymphedema (therapy)</term>
<term>Lymphoscintigraphy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Physical Therapy Modalities</term>
<term>Sensitivity and Specificity</term>
<term>Technetium Compounds</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antimony</term>
<term>Technetium Compounds</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Extremities</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphoscintigraphy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Physical Therapy Modalities</term>
<term>Sensitivity and Specificity</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We investigated whether baseline lymphscintigraphic findings can predict long-term response to complex physical therapy (CPT) in patients with early stage extremity lymphedema. Twenty patients with unilateral extremity lymphedema of clinical stage I or II underwent CPT after baseline lymphscintigraphy. Therapeutic responses (good vs. poor) were evaluated at 1 year post-CPT based on changes in skin status and subjective symptoms, and percent volume reductions and compared with clinical factors and lymphscintigraphic findings. Eleven patients showed good response to CPT with significant volume reduction of edematous extremities, and no significant volume reduction was observed in the remaining 9. Patients with good or poor responses to CPT showed no significant differences in terms of clinical variables. However, significant differences were observed between the lymphscintigraphic findings of these patients. More specifically, a lymphscintigraphic finding of main lymphatic vessels without collateral lymphatic vessels was the best predictor for a good response to CPT; the sensitivity, specificity and accuracy of this lymphscintigraphic finding is 91% (10/11), 100% (9/9) and 95% (19/20), respectively. In patients with unilateral extremity lymphedema of early stage, baseline lymphscintigraphy may usefully predict long-term response to CPT.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18365531</PMID>
<DateCreated><Year>2008</Year>
<Month>03</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted><Year>2008</Year>
<Month>06</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>11</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0024-7766</ISSN>
<JournalIssue CitedMedium="Print"><Volume>40</Volume>
<Issue>4</Issue>
<PubDate><Year>2007</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Lymphology</Title>
<ISOAbbreviation>Lymphology</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema.</ArticleTitle>
<Pagination><MedlinePgn>172-6</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We investigated whether baseline lymphscintigraphic findings can predict long-term response to complex physical therapy (CPT) in patients with early stage extremity lymphedema. Twenty patients with unilateral extremity lymphedema of clinical stage I or II underwent CPT after baseline lymphscintigraphy. Therapeutic responses (good vs. poor) were evaluated at 1 year post-CPT based on changes in skin status and subjective symptoms, and percent volume reductions and compared with clinical factors and lymphscintigraphic findings. Eleven patients showed good response to CPT with significant volume reduction of edematous extremities, and no significant volume reduction was observed in the remaining 9. Patients with good or poor responses to CPT showed no significant differences in terms of clinical variables. However, significant differences were observed between the lymphscintigraphic findings of these patients. More specifically, a lymphscintigraphic finding of main lymphatic vessels without collateral lymphatic vessels was the best predictor for a good response to CPT; the sensitivity, specificity and accuracy of this lymphscintigraphic finding is 91% (10/11), 100% (9/9) and 95% (19/20), respectively. In patients with unilateral extremity lymphedema of early stage, baseline lymphscintigraphy may usefully predict long-term response to CPT.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hwang</LastName>
<ForeName>J H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Choi</LastName>
<ForeName>J Y</ForeName>
<Initials>JY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>J Y</ForeName>
<Initials>JY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hyun</LastName>
<ForeName>S H</ForeName>
<Initials>SH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Choi</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Choe</LastName>
<ForeName>Y S</ForeName>
<Initials>YS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>K H</ForeName>
<Initials>KH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>B T</ForeName>
<Initials>BT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Lymphology</MedlineTA>
<NlmUniqueID>0155112</NlmUniqueID>
<ISSNLinking>0024-7766</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017556">Technetium Compounds</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C019096">technetium Tc 99m antimony sulfide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9IT35J3UV3</RegistryNumber>
<NameOfSubstance UI="D000965">Antimony</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000965" MajorTopicYN="N">Antimony</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005121" MajorTopicYN="Y">Extremities</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061305" MajorTopicYN="Y">Lymphoscintigraphy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D026741" MajorTopicYN="Y">Physical Therapy Modalities</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017556" MajorTopicYN="N">Technetium Compounds</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>6</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">18365531</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003328 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003328 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:18365531
   |texte=   Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:18365531" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema.

Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki